BSXStock
Verdicts genuinely change. Free email alert the moment BSX's does — no target price to set, unlike a price alert.
Stable Ratio screen, 7 of 7 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it
Whether this company clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Trade plan
Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
BSX is currently considered halal (Sharia-compliant), per our in-house ratio engine (last assessed 2026-09-30). See the full ratio breakdown and business-activity screen below for the reasoning.
This sits among 434 compliant Healthcare stocks we track. See compliant Healthcare stocks →
How the status reached this point
Compliant · status tracked since Nov 17, 2026
No change to BSX’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.
Read once a day from our own screen, last on Nov 17, 2026. The per-methodology record is under “What changed, and when” in the in-house research.
🕌 In-house Compliance Research
Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.
AAOIFI divides by the market cap: $64.4B as of 2026-11-16. At the 2026-11-18 close it is about $63.4B (the stored market cap moved by the share price since, not a new share count), and at that cap AAOIFI's interest-bearing debt ratio would read 18.9% (18.6% at the stored cap, against a 30% line) and interest-bearing investments ratio would read 1.3% (1.2% at the stored cap, against a 30% line). The published verdict changes only when the company is re-screened.
Business activity: cleared (no excluded categories detected)
AAOIFI Pass 3 of 3 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 18.56% | 30.00% | Pass(11.4pp buffer) |
| Interest-bearing investments | 1.24% | 30.00% | Pass(28.8pp buffer) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
Usmani Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 26.29% | 33.00% | Pass(6.7pp buffer) |
| Interest-bearing investments | 1.75% | 33.00% | Pass(31.2pp buffer) |
| Non-liquid assets | 98.25% | at least 20.00% | Pass(78.2pp above the floor) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
MSCI Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 26.29% | 33.33% | Pass(7.0pp buffer) |
| Cash + interest-bearing securities | 1.75% | 33.33% | Pass(31.6pp buffer) |
| Accounts receivable | 1.75% | 33.33% | Pass(31.6pp buffer) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
FTSE Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 26.29% | 33.33% | Pass(7.0pp buffer) |
| Cash + interest-bearing securities | 1.75% | 33.33% | Pass(31.6pp buffer) |
| Accounts receivable | 1.75% | 50.00% | Pass(48.2pp buffer) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
Dow Jones Islamic Market Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 10.03% | 33.00% | Pass(23.0pp buffer) |
| Cash + interest-bearing securities | 0.67% | 33.00% | Pass(32.3pp buffer) |
| Accounts receivable | 0.00% | 33.00% | Pass(33.0pp buffer) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
S&P Shariah Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 10.45% | 33.00% | Pass(22.5pp buffer) |
| Cash + interest-bearing securities | 0.70% | 49.00% | Pass(48.3pp buffer) |
| Accounts receivable | 0.00% | 49.00% | Pass(49.0pp buffer) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
MSCI M-Series Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 10.45% | 33.33% | Pass(22.9pp buffer) |
| Cash + interest-bearing securities | 0.70% | 33.33% | Pass(32.6pp buffer) |
| Accounts receivable | 0.70% | 49.00% | Pass(48.3pp buffer) |
| Non-permissible income | 0.00% | 5.00% | Pass(5.0pp buffer) |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
How close is it to flipping?
Every current reading against its own line, closest first. A verdict is only as durable as that distance.
The numbers the ratios are built from
Read from BSX's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.
| Line | Figure | As reported | Read from |
|---|---|---|---|
| RevenueTotal revenue for the period | $20.1B | 2026-09-30 | RevenueFromContractWithCustomerExcludingAssessedTax |
| Interest-bearing debtShort and long-term borrowings | $12.0B | 2026-09-30 | LongTermDebtAndCapitalLeaseObligations, DebtCurrent |
| Cash and interest-bearing securitiesCash, equivalents and marketable securities | $797.0M | 2026-09-30 | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
| Total assetsBalance sheet total | $45.5B | 2026-09-30 | Assets |
| Market capDenominator for AAOIFI | $64.4B | live quote | price x shares |
| 36-month average market capDenominator for S&P Shariah and MSCI M-Series | $115.0B | 756 trading days | closes x shares |
| 24-month average market capDenominator for Dow Jones Islamic Market | $120.0B | 504 trading days | closes x shares |
| Non-permissible revenueInterest and excluded income | $0 | 2026-09-30 | no interest-income tag reported in 3+ years (treated as $0) |
Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.
Sources
Filing information. Balance sheet as of 2026-09-30. Income statement as of 2026-09-30. Screened 2026-11-16.
Filing links appear after the next screen: this row was screened before filing citations were recorded.
-
Total assets$45.5B
Assets· balance sheet as of 2026-09-30 -
Interest-bearing debt$12.0B
LongTermDebtAndCapitalLeaseObligations, DebtCurrent· balance sheet as of 2026-09-30 -
Cash and interest-bearing securities$797.0M
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents· balance sheet as of 2026-09-30 -
Receivables$0
no receivables tag reported in 3+ years (treated as $0)· balance sheet as of 2026-09-30 -
Revenue$20.1B
RevenueFromContractWithCustomerExcludingAssessedTax· income statement as of 2026-09-30 -
Interest income (non-permissible)$0
no interest-income tag reported in 3+ years (treated as $0)· income statement as of 2026-09-30 -
Market cap$64.4BMarket-data quote at screen time, 2026-11-16 · not a filing figure, so no link
What changed, and when
Verdict history for BSX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-09-07 No change recorded No verdict change for BSX has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.
Tracked since 2026-09-07.
Revenue by business segment
How BSX’s $20.1B of revenue for the fiscal year 2025-01-01 to 2025-12-31 splits across what it sells, as the company tags it in its own 10-K.
| Segment | Share | Revenue |
|---|---|---|
| Interventional Cardiology & Vascular Therapies | 23.1% | $4.6B |
| Electrophysiology | 16.6% | $3.3B |
| Endoscopy | 14.5% | $2.9B |
| Urology | 13.5% | $2.7B |
| Cardiac Rhythm Management | 11.6% | $2.3B |
| Watchman | 9.8% | $2.0B |
| Neuromodulation | 6.0% | $1.2B |
| Interventional Oncology & Embolization | 5.0% | $996.0M |
These are the company’s own segment names and figures. They do not say whether a line of business is permissible; our business-activity screen does.
Source: 10-K filed 2026-02-17 (accession 0000885725-26-000010), read from its XBRL on SEC EDGAR. Shares are of total revenue; subtotals and overlapping cuts the filing also tags are left out, so the lines add up to the total.
What would change the status
The headline verdict is the majority of the decided ratio standards — 7 pass and 0 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-16.
No standard's deciding ratio sits within 3 points of its line.
The ratios that move with the share price
AAOIFI's debt ratio is $12.0B debt over a market cap of $64.4B (as of 2026-11-16), 18.6% against a 30% line.
At the 2026-11-18 close the market cap is about $63.4B (the stored cap moved by the share price since), so this ratio would read 18.9%; the line is -37% from there. The published status changes only when the company is re-screened.
It would fail if the market cap fell to $39.8B (-38%), about $27.49 a share against $44.42 implied by the screen's own figures.
AAOIFI would then fail; the majority verdict would stay Compliant (6 of 7 decided standards passing).
At the screen's market cap, debt would have to rise by $7.4B to reach the line.
AAOIFI would then fail, and the majority verdict would move from Compliant to Not compliant (3 of 7 decided standards passing, counting every standard that divides the same figure).
AAOIFI's investments ratio (1.2% against a 30% line) would only fail if the market cap fell by 96%, to $2.7B. At the 2026-11-18 close it would read 1.3%.
Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.
Shariah-compliant alternatives
Compliant companies in Medical Devices listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.
| Company | Market cap | Price, day |
|---|---|---|
| ABTAbbott Laboratories | $201.9B | — |
| SYKStryker Corp. | $125.7B | — |
| MDTMedtronic Plc | $117.8B | — |
| EWEdwards Lifesciences Corp | $52.2B | — |
| DXCMDexcom Inc | $34.4B | — |
A dash means no fresh quote is cached for that symbol; this list does not fetch one.
Funds that hold BSX
37 of the 198 funds whose filed holdings we currently hold own BSX shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns BSX.
Shariah funds| Fund | BSX in fund | Fund compliant by weight |
|---|---|---|
| MNZL Manzil Russell Halal USA Broad Market ETF | 0.24% | 88% |
| SPUS SP Funds S&P 500 Sharia Industry Exclusions ETF | 0.19% | 79% |
| HLAL Wahed FTSE USA Shariah ETF | 0.18% | 72% |
Widely held U.S. index funds. If you own one, you own BSX through it. None of them is a Shariah fund; the last column is our look-through of each.
| Fund | BSX in fund | Fund compliant by weight |
|---|---|---|
| RSP Invesco S&P 500 Equal Weight ETF | 0.19% | 44% |
| VUG VANGUARD GROWTH INDEX FUND | 0.10% | 63% |
| SPY | 0.10% | 56% |
| VOO VANGUARD 500 INDEX FUND | 0.10% | 56% |
| SPYM State Street(R) SPDR(R) Portfolio S&P 500(R) ETF | 0.10% | 56% |
| IVV iShares Core S&P 500 ETF | 0.10% | 56% |
| SCHB Schwab U.S. Broad Market ETF | 0.10% | 53% |
| VTI VANGUARD TOTAL STOCK MARKET INDEX FUND | 0.09% | 54% |
| ITOT iShares Core S&P Total U.S. Stock Market ETF | 0.09% | 54% |
| Fund | BSX in fund | Fund compliant by weight |
|---|---|---|
| LMVTX ClearBridge Value Fund | 0.88% | 44% |
| MXKJX Empower Mid Cap Value Fund | 0.71% | 35% |
| SNPG Xtrackers S&P 500 Growth Scored & Screened ETF | 0.36% | 67% |
| MXHAX Empower Large Cap Value Fund | 0.25% | 39% |
| GSEW Goldman Sachs Equal Weight U.S. Large Cap Equity ETF | 0.20% | 47% |
| TAFFX Growth Fund of America | 0.19% | 54% |
| RSESX U.S. Strategic Equity Fund | 0.19% | not computed |
| RNNEX New Economy Fund | 0.17% | 60% |
| MXETX Empower Core Strategies: U.S. Equity Fund | 0.15% | 49% |
| BBUS JPMORGAN BETABUILDERS U.S. EQUITY ETF | 0.11% | 53% |
15 more funds
| Fund | BSX in fund | Fund compliant by weight |
|---|---|---|
| MSXMX NYLIM S&P 500 Index Fund | 0.11% | 53% |
| BKLC BNY Mellon US Large Cap Core Equity ETF | 0.11% | 54% |
| VONE VANGUARD RUSSELL 1000 INDEX FUND | 0.10% | 53% |
| MIEYX MM S&P 500 Index Fund | 0.10% | 56% |
| VTHR VANGUARD RUSSELL 3000 INDEX FUND | 0.10% | 52% |
| FSKAX Fidelity Total Market Index Fund | 0.10% | 51% |
| EQAL Invesco Russell 1000 Equal Weight ETF | 0.10% | 42% |
| TEQWX Nuveen Equity Index Fund | 0.10% | 51% |
| TILT FlexShares Morningstar US Market Factor Tilt Index Fund | 0.09% | 44% |
| PHDG Invesco S&P 500 Downside Hedged ETF | 0.09% | 43% |
| JAFEX Total Stock Market Index Trust | 0.08% | 52% |
| BBB Cyber Hornet S&P 500 and Bitcoin 75/25 Strategy ETF | 0.08% | 43% |
| SLGAX SIMT Large Cap Fund | 0.06% | 49% |
| AVUS Avantis U.S. Equity ETF | 0.05% | 49% |
| SPGEX Symmetry Panoramic Global Equity Fund | 0.02% | not computed |
Sorted by BSX’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names BSX once, so a bond is not counted as the shares; 2 more funds name BSX in a way we cannot separate from its bonds, and are not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| David Shaw | D. E. Shaw & Co. | $1,037M | 0.5% | 2026-09-30 |
| Ken Griffin | Citadel Advisors | $794M | 0.1% | 2026-09-30 |
| Dodge & Cox | Dodge & Cox | $653M | 0.4% | 2026-09-30 |
| First Pacific Advisors | First Pacific Advisors | $102M | 1.2% | 2026-09-30 |
| Israel Englander | Millennium Management | $99M | 0.0% | 2026-09-30 |
| Peter Brown | Renaissance Technologies | $77M | 0.1% | 2026-09-30 |
| Joel Greenblatt | Gotham Asset Management | $61M | 0.1% | 2026-09-30 |
| Sarah Ketterer | Causeway Capital Management | $39M | 0.4% | 2026-09-30 |
| Steven Cohen | Point72 Asset Management | $36M | 0.0% | 2026-09-30 |
| Louis Bacon | Moore Capital Management | $30M | 0.6% | 2026-09-30 |
| Jefferies | Jefferies Financial Group | $25M | 0.2% | 2026-09-30 |
| Ray Dalio | Bridgewater Associates | $19M | 0.1% | 2026-09-30 |
| Paul Tudor Jones | Tudor Investment Corp | $19M | 0.0% | 2026-09-30 |
| Ken Fisher | Fisher Asset Management | $13M | 0.0% | 2026-09-30 |
| Mario Gabelli | GAMCO Investors | $4M | 0.0% | 2026-09-30 |
| Larry Robbins | Glenview Capital Management | $3M | 0.1% | 2026-09-30 |
| Wahed Invest | Wahed Invest LLC | $2M | 0.2% | 2026-06-30 |
| Jeremy Grantham | GMO | $1M | 0.0% | 2026-09-30 |
| Saturna Capital | Amana Mutual Funds Trust | $1M | 0.0% | 2026-09-30 |
| Diamond Hill | Diamond Hill Capital Management | $1M | 0.0% | 2026-09-30 |
| Sallie Krawcheck | Ellevest | $1M | 0.1% | 2026-09-30 |
| Mairs & Power | Mairs & Power | $0M | 0.0% | 2026-09-30 |
| Lee Ainslie | Maverick Capital | $0M | 0.0% | 2026-09-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 48.00 | NEUTRAL |
| Stochastic %K (14) | 36.45 | NEUTRAL |
| CCI (20) | -44.95 | NEUTRAL |
| Williams %R (14) | -63.55 | NEUTRAL |
| MACD (12,26,9) | -0.06 | SELL |
| ROC (10) | -4.76 | SELL |
| Momentum (10) | -2.18 | SELL |
| EMA (10) | 43.91 | SELL |
| SMA (10) | 44.01 | SELL |
| EMA (20) | 44.01 | SELL |
| SMA (20) | 44.16 | SELL |
| EMA (30) | 44.12 | SELL |
| SMA (30) | 44.06 | SELL |
| EMA (50) | 44.54 | SELL |
| SMA (50) | 43.86 | SELL |
| EMA (100) | 47.26 | SELL |
| SMA (100) | 45.40 | SELL |
| EMA (200) | 57.47 | SELL |
| SMA (200) | 53.41 | SELL |
About BSX
Healthcare · Medical Devices
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Background via Yahoo Finance — informational, not part of the verdict.
Latest Signal — 2026-10-29
Stop 41.90 Now 43.64 Target 45.37
🟡 BULLISH LEAN
The main driver: RSI in healthy zone, Wall Street broadly bullish, insiders buying with real money. More signals pointing up than down. Not full confluence yet, but the weight of evidence is bullish. Use `!alert BSX [level]` to catch the entry, or `!plan BSX` to size small.
Scores: 3 bullish / 1 bearish
Weak — low conviction, small size or skip
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | RANGING | 64 |
| ⏰ 4H | BEARISH | 55 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is this a fatwa?
No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.
Why can the standards disagree?
Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.
How often is this re-screened?
Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.
Do I need to purify dividends?
If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
CLUSTER BUY 6 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-10 · Asset managers net 914130 (-14454)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.